Integra Lifesciences Holdings Stock Market Value
| IART Stock | USD 10.88 0.25 2.25% |
| Symbol | Integra |
Is there potential for Health Care Equipment & Supplies market expansion? Will Integra introduce new products? Factors like these will boost the valuation of Integra LifeSciences. Market participants price Integra higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about Integra LifeSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.004 | Earnings Share (6.47) | Revenue Per Share | Quarterly Revenue Growth 0.056 | Return On Assets |
Understanding Integra LifeSciences requires distinguishing between market price and book value, where the latter reflects Integra's accounting equity. The concept of intrinsic value—what Integra LifeSciences' is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Integra LifeSciences' price substantially above or below its fundamental value.
Please note, there is a significant difference between Integra LifeSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Integra LifeSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Integra LifeSciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Integra LifeSciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Integra LifeSciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Integra LifeSciences.
| 10/31/2025 |
| 01/29/2026 |
If you would invest 0.00 in Integra LifeSciences on October 31, 2025 and sell it all today you would earn a total of 0.00 from holding Integra LifeSciences Holdings or generate 0.0% return on investment in Integra LifeSciences over 90 days. Integra LifeSciences is related to or competes with Tandem Diabetes, Pacific Biosciences, Maravai Lifesciences, Septerna Common, Fortrea Holdings, Myriad Genetics, and Bicara Therapeutics. Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments ... More
Integra LifeSciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Integra LifeSciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Integra LifeSciences Holdings upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 26.18 | |||
| Value At Risk | (4.33) | |||
| Potential Upside | 5.4 |
Integra LifeSciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Integra LifeSciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Integra LifeSciences' standard deviation. In reality, there are many statistical measures that can use Integra LifeSciences historical prices to predict the future Integra LifeSciences' volatility.| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.50) | |||
| Total Risk Alpha | (0.78) | |||
| Treynor Ratio | (0.36) |
Integra LifeSciences January 29, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | (0.35) | |||
| Mean Deviation | 2.46 | |||
| Coefficient Of Variation | (988.68) | |||
| Standard Deviation | 4.04 | |||
| Variance | 16.36 | |||
| Information Ratio | (0.12) | |||
| Jensen Alpha | (0.50) | |||
| Total Risk Alpha | (0.78) | |||
| Treynor Ratio | (0.36) | |||
| Maximum Drawdown | 26.18 | |||
| Value At Risk | (4.33) | |||
| Potential Upside | 5.4 | |||
| Skewness | (2.52) | |||
| Kurtosis | 15.84 |
Integra LifeSciences Backtested Returns
Integra LifeSciences holds Efficiency (Sharpe) Ratio of -0.0415, which attests that the entity had a -0.0415 % return per unit of risk over the last 3 months. Integra LifeSciences exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Integra LifeSciences' Market Risk Adjusted Performance of (0.35), risk adjusted performance of (0.07), and Standard Deviation of 4.04 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 1.17, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Integra LifeSciences will likely underperform. At this point, Integra LifeSciences has a negative expected return of -0.12%. Please make sure to check out Integra LifeSciences' maximum drawdown, accumulation distribution, as well as the relationship between the Accumulation Distribution and market facilitation index , to decide if Integra LifeSciences performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.52 |
Good reverse predictability
Integra LifeSciences Holdings has good reverse predictability. Overlapping area represents the amount of predictability between Integra LifeSciences time series from 31st of October 2025 to 15th of December 2025 and 15th of December 2025 to 29th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Integra LifeSciences price movement. The serial correlation of -0.52 indicates that about 52.0% of current Integra LifeSciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.52 | |
| Spearman Rank Test | -0.46 | |
| Residual Average | 0.0 | |
| Price Variance | 0.49 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Integra Stock Analysis
When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.